| Product Code: ETC7536538 | Publication Date: Sep 2024 | Product Type: Market Research Report | ||
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India allogeneic cell therapy market import shipment experienced a declining trend with a negative CAGR from 2020 to 2024. The growth rate between 2023 and 2024 further plummeted, indicating a significant slowdown in market expansion. The market exhibited a clear deceleration and lost momentum during this period.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Allogeneic Cell Therapy Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Allogeneic Cell Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 India Allogeneic Cell Therapy Market - Industry Life Cycle |
3.4 India Allogeneic Cell Therapy Market - Porter's Five Forces |
3.5 India Allogeneic Cell Therapy Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.6 India Allogeneic Cell Therapy Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
4 India Allogeneic Cell Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in India leading to a higher demand for cell therapy treatments. |
4.2.2 Growing investments by both government and private sector in healthcare infrastructure and research development. |
4.2.3 Rising awareness and acceptance of cell therapy as an effective treatment option among patients and healthcare professionals. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and lengthy approval processes for cell therapy products in India. |
4.3.2 High costs associated with allogeneic cell therapy treatments limiting access to a broader patient population. |
4.3.3 Limited skilled workforce and expertise in the field of cell therapy in India. |
5 India Allogeneic Cell Therapy Market Trends |
6 India Allogeneic Cell Therapy Market, By Types |
6.1 India Allogeneic Cell Therapy Market, By Therapy Type |
6.1.1 Overview and Analysis |
6.1.2 India Allogeneic Cell Therapy Market Revenues & Volume, By Therapy Type, 2021- 2031F |
6.1.3 India Allogeneic Cell Therapy Market Revenues & Volume, By Stem Cell, 2021- 2031F |
6.1.4 India Allogeneic Cell Therapy Market Revenues & Volume, By Non-stem Cell, 2021- 2031F |
6.2 India Allogeneic Cell Therapy Market, By Therapeutic Area |
6.2.1 Overview and Analysis |
6.2.2 India Allogeneic Cell Therapy Market Revenues & Volume, By Hematological Disorders, 2021- 2031F |
6.2.3 India Allogeneic Cell Therapy Market Revenues & Volume, By Dermatological Disorders, 2021- 2031F |
7 India Allogeneic Cell Therapy Market Import-Export Trade Statistics |
7.1 India Allogeneic Cell Therapy Market Export to Major Countries |
7.2 India Allogeneic Cell Therapy Market Imports from Major Countries |
8 India Allogeneic Cell Therapy Market Key Performance Indicators |
8.1 Patient enrollment in clinical trials for allogeneic cell therapy treatments. |
8.2 Number of research partnerships and collaborations between Indian firms and international players in the cell therapy market. |
8.3 Government funding allocated specifically for cell therapy research and development in India. |
9 India Allogeneic Cell Therapy Market - Opportunity Assessment |
9.1 India Allogeneic Cell Therapy Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.2 India Allogeneic Cell Therapy Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
10 India Allogeneic Cell Therapy Market - Competitive Landscape |
10.1 India Allogeneic Cell Therapy Market Revenue Share, By Companies, 2024 |
10.2 India Allogeneic Cell Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here